Related Experiment Video

Updated: Jul 9, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

[Evolution of the surgical strategy in hypertrophic cardiomyopathy: case studies of eight patients]

Thomas Joudinaud1, Erwan Flecher, Ulrich Hvass

  • 1Service de chirurgie cardiaque, hôpital Bichat, 46, rue Henri-Huchard, 75018 Paris, France. thomas.joudinaud@bch.aphp.fr <thomas.joudinaud@bch.aphp.fr>

Annales De Cardiologie Et D'Angeiologie
|December 7, 2007
PubMed

Insights

Surgical treatment significantly reduces left ventricular outflow tract gradients in hypertrophic cardiomyopathy patients. This approach offers a vital option for managing obstructive hypertrophic cardiomyopathy, especially when other treatments fail.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Inherited Cardiovascular Diseases

Background:

  • Hypertrophic cardiomyopathy (HCM) is an inherited condition causing left ventricular hypertrophy, diastolic dysfunction, and arrhythmias, posing a risk of sudden cardiac death.
  • Surgical strategies for HCM have evolved, particularly for patients with left ventricular outflow tract (LVOT) gradients.

Observation:

  • A retrospective study analyzed eight operated HCM patients.
  • Pre- and post-operative echocardiographic data were assessed, with follow-up via cardiologist contact.

Findings:

  • Patients were categorized into groups based on LVOT obstruction, associated lesions, endocarditis, or post-operative complications.
  • A significant reduction in mean LVOT gradient was observed post-surgery and maintained at four years.

Implications:

  • Surgical management of obstructive HCM is a key option for young patients, especially if septal ablation fails or other surgical issues are present.
  • Dual-chamber pacing remains indicated for elderly patients with HCM.
Abstract

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...